| Ticker Details |
Bruker Corporation Common Stock
Bruker Corp is a developer, manufacturer and distributor of scientific instruments and analytical and dignostic solutions that enable customers to explore life and materials at microscopic, molecular and cellular levels.
|
| IPO Date: |
July 2, 2003 |
| Sector: |
Healthcare |
| Industry: |
Life Sciences Tools and Services |
| Market Cap: |
$5.82B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.42 | 1.68%
|
| Avg Daily Range (30 D): |
$1.04 | 2.29%
|
| Avg Daily Range (90 D): |
$0.90 | 2.05%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.68M |
| Avg Daily Volume (30 D): |
2.3M |
| Avg Daily Volume (90 D): |
2.14M |
| Trade Size |
| Avg Trade Size (Sh.): |
92 |
| Avg Trade Size (Sh.) (30 D): |
62 |
| Avg Trade Size (Sh.) (90 D): |
63 |
| Institutional Trades |
| Total Institutional Trades: |
10,074 |
| Avg Institutional Trade: |
$2.73M |
| Avg Institutional Trade (30 D): |
$3.91M |
| Avg Institutional Trade (90 D): |
$4.18M |
| Avg Institutional Trade Volume: |
.07M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$5.14M |
| Avg Closing Trade (30 D): |
$15.63M |
| Avg Closing Trade (90 D): |
$15.03M |
| Avg Closing Volume: |
109.55K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
|
$-.41
|
$.05
|
|
Diluted EPS
|
|
$-.41
|
$.05
|
|
Revenue
|
|
$860.5M
|
$797.4M
|
|
Gross Profit
|
|
$379.4M
|
$357.9M
|
|
Net Income / Loss
|
|
$-58.5M
|
$4.2M
|
|
Operating Income / Loss
|
|
$-51.8M
|
$11.9M
|
|
Cost of Revenue
|
|
$481.1M
|
$439.5M
|
|
Net Cash Flow
|
|
$201.1M
|
$-91.5M
|
|
PE Ratio
|
|
|
|
|
|
|
